drugset / Trial / NCT05446493

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

NCT05446493

Phase 4 Completed 60 enrolled Aswan University
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

Timeline

Start
2019-04-01
Primary completion
2021-03-15
Completion
2022-01-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 5 mg

Indications